{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:16:23Z","timestamp":1791321383584,"version":"4.3.1"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/nrrheum.2011.139","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T08:16:44Z","timestamp":1317111404000},"page":"664-675","source":"Crossref","is-referenced-by-count":126,"title":["Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis"],"prefix":"10.1038","volume":"7","author":[{"given":"Angela B.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"BFnrrheum2011139_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0889-857X(05)70350-1","volume":"23","author":"LG Rider","year":"1997","unstructured":"Rider, L. G. & Miller, F. W. Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum. Dis. Clin. N. Am. 23, 619\u2013655 (1997).","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"BFnrrheum2011139_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","volume":"1184","author":"AL Mammen","year":"2010","unstructured":"Mammen, A. L. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann. NY Acad. Sci. 1184, 134\u2013153 (2010).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum2011139_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-3476(64)80325-5","volume":"64","author":"S Bitnum","year":"1964","unstructured":"Bitnum, S., Daeschner, C. W. Jr, Travis, L. B., Dodge, W. F. & Hopps, H. C. Dermatomyositis. J. Pediatr. 64, 101\u2013131 (1964).","journal-title":"J. Pediatr."},{"key":"BFnrrheum2011139_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli, A. et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res. 62, 63\u201372 (2010).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum2011139_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","volume":"83","author":"K Dank\u00f3","year":"2004","unstructured":"Dank\u00f3, K., Ponyi, A., Constantin, T., Borgulya, G. & Szegedi, G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 83, 35\u201342 (2004).","journal-title":"Medicine"},{"key":"BFnrrheum2011139_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez, E. P. et al. US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Care Res. 49, 300\u2013305 (2003).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum2011139_CR7","first-page":"1329","volume":"17","author":"CV Oddis","year":"1990","unstructured":"Oddis, C. V., Conte, C. G., Steen, V. D. & Medsger, T. A. Jr. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963\u20131982. J. Rheumatol. 17, 1329\u20131334 (1990).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1157\/13113285","volume":"129","author":"H Vargas-Leguas","year":"2007","unstructured":"Vargas-Leguas, H. et al. Polymyositis-dermatomyositis: incidence in Spain (1997\u20132004). Med. Clin. (Barc.) 129, 721\u2013724 (2007).","journal-title":"Med. Clin. (Barc.)"},{"key":"BFnrrheum2011139_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1756-185X.2010.01472.x","volume":"13","author":"S Cox","year":"2010","unstructured":"Cox, S., Limaye, V., Hill, C., Blumbergs, P. & Roberts-Thomson, P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int. J. Rheum. Dis. 13, 117\u2013124 (2010).","journal-title":"Int. J. Rheum. Dis."},{"key":"BFnrrheum2011139_CR10","first-page":"117","volume":"29","author":"D Guseinova","year":"2011","unstructured":"Guseinova, D. et al. Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. Clin. Exp. Rheumatol. 29, 117\u2013124 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2011139_CR11","first-page":"782","volume":"28","author":"PR Mathiesen","year":"2010","unstructured":"Mathiesen, P. R., Zak, M., Herlin, T. & Nielsen, S. M. Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin. Exp. Rheumatol. 28, 782\u2013789 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2011139_CR12","first-page":"1031","volume":"27","author":"JO Sato","year":"2009","unstructured":"Sato, J. O. et al. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases. Clin. Exp. Rheumatol. 27, 1031\u20131038 (2009).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2011139_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2010.1977","volume":"305","author":"LG Rider","year":"2011","unstructured":"Rider, L. G. & Miller, F. W. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 305, 183\u2013190 (2011).","journal-title":"JAMA"},{"key":"BFnrrheum2011139_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis. N. Engl. J. Med. 292, 344\u2013347 (1975).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2011139_CR15","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/rheumatology\/kem088","volume":"46","author":"J Tomasova Studynkova","year":"2007","unstructured":"Tomasova Studynkova, J., Charvat, F., Jarosova, K. & Vencovsky, J. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology 46, 1174\u20131179 (2007).","journal-title":"Rheumatology"},{"key":"BFnrrheum2011139_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/art.24411","volume":"60","author":"CM Lopez de Padilla","year":"2009","unstructured":"Lopez de Padilla, C. M., Vallejo, A. N., Lacomis, D., McNallan, K. & Reed, A. M. Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis. Arthritis Rheum. 60, 1160\u20131172 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR17","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/art.27379","volume":"62","author":"RA Ostrowski","year":"2010","unstructured":"Ostrowski, R. A., Sullivan, C. L., Seshadri, R., Morgan, G. A. & Pachman, L. M. Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis. Arthritis Rheum. 62, 1533\u20131538 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR18","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1002\/art.23960","volume":"58","author":"E Stringer","year":"2008","unstructured":"Stringer, E., Singh-Grewal, D. & Feldman, B. M. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum. 58, 3585\u20133592 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR19","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/art.24904","volume":"60","author":"LG Rider","year":"2009","unstructured":"Rider, L. G. et al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthriti Rheum. 60, 3425\u20133435 (2009).","journal-title":"Arthriti Rheum."},{"key":"BFnrrheum2011139_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0016-5085(86)90944-3","volume":"90","author":"M Horowitz","year":"1986","unstructured":"Horowitz, M., McNeil, J. D., Maddern, G. J., Collins, P. J. & Shearman, D. J. Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis. Gastroenterology 90, 434\u2013439 (1986).","journal-title":"Gastroenterology"},{"key":"BFnrrheum2011139_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1055\/s-2007-985666","volume":"28","author":"M Fathi","year":"2007","unstructured":"Fathi, M., Lundberg, I. E. & Tomling, G. Pulmonary complications of polymyositis and dermatomyositis. Semin. Respir. Crit. Care Med. 28, 451\u2013458 (2007).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"BFnrrheum2011139_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/BOR.0b013e328331927e","volume":"21","author":"CA Lowry","year":"2009","unstructured":"Lowry, C. A. & Pilkington, C. A. Juvenile dermatomyositis: extramuscular manifestations and their management. Curr. Opin. Rheumatol. 21, 575\u2013580 (2009).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2011139_CR23","first-page":"2152","volume":"23","author":"MB Oliveri","year":"1996","unstructured":"Oliveri, M. B., Palermo, R., Mautalen, C. & Hubscher, O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J. Rheumatol. 23, 2152\u20132155 (1996).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","volume":"103","author":"SL Bowyer","year":"1983","unstructured":"Bowyer, S. L., Blane, C. E., Sullivan, D. B. & Cassidy, J. T. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J. Pediatr. 103, 882\u2013888 (1983).","journal-title":"J. Pediatr."},{"key":"BFnrrheum2011139_CR25","doi-asserted-by":"publisher","first-page":"R159","DOI":"10.1186\/ar2841","volume":"11","author":"N Eidelman","year":"2009","unstructured":"Eidelman, N. et al. Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies. Arthritis Res. Ther. 11, R159 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2011139_CR26","first-page":"610","volume":"28","author":"C Huemer","year":"2001","unstructured":"Huemer, C. et al. Lipodystrophy in patients with juvenile dermatomyositis\u2014evaluation of clinical and metabolic abnormalities. J. Rheumatol. 28, 610\u2013615 (2001).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR27","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/j.jaad.2006.07.010","volume":"57","author":"LA Lee","year":"2007","unstructured":"Lee, L. A. & Hobbs, K. F. Lipodystrophy and metabolic abnormalities in a case of adult dermatomyositis. J. Am. Acad. Dermatol. 57, S85\u2013S87 (2007).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFnrrheum2011139_CR28","doi-asserted-by":"publisher","unstructured":"Marie, I. et al. Short term and long term outcome of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum. http:dx.doi.org\/10.1002\/art.30513","DOI":"10.1002\/art.30513"},{"key":"BFnrrheum2011139_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/ard.2010.131433","volume":"70","author":"H Sanner","year":"2011","unstructured":"Sanner, H. et al. Pulmonary outcome in juvenile dermatomyositis: a case-control study. Ann. Rheum. Dis. 70, 86\u201391 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2011139_CR30","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors, G. R., Christopher-Stine, L., Oddis, C. V. & Danoff, S. K. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138, 1464\u20131474 (2010).","journal-title":"Chest"},{"key":"BFnrrheum2011139_CR31","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato, S. et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 52, 1571\u20131576 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR32","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/ard.2010.137968","volume":"70","author":"T Schwartz","year":"2011","unstructured":"Schwartz, T., Sanner, H., Husebye, T., Flato, B. & Sjaastad, I. Cardiac dysfunction in juvenile dermatomyositis: a case-control study. Ann. Rheum. Dis. 70, 766\u2013771 (2011).","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 4","key":"BFnrrheum2011139_CR33","doi-asserted-by":"publisher","first-page":"iv18","DOI":"10.1093\/rheumatology\/kel311","volume":"45","author":"IE Lundberg","year":"2006","unstructured":"Lundberg, I. E. The heart in dermatomyositis and polymyositis. Rheumatology (Oxford) 45 (Suppl. 4), iv18\u2013iv21 (2006).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR34","first-page":"590","volume":"34","author":"MJ Santos","year":"2009","unstructured":"Santos, M. J. & Fonseca, J. E. Metabolic syndrome, inflammation and atherosclerosis\u2014the role of adipokines in health and in systemic inflammatory rheumatic diseases. Acta Reumatol. Port. 34, 590\u2013598 (2009).","journal-title":"Acta Reumatol. Port."},{"key":"BFnrrheum2011139_CR35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2007.08.024","volume":"57","author":"RQ Klein","year":"2007","unstructured":"Klein, R. Q., Teal, V., Taylor, L., Troxel, A. B. & Werth, V. P. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J. Am. Acad. Dermatol. 57, 937\u2013943 (2007).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFnrrheum2011139_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/BOR.0b013e32833f1987","volume":"22","author":"S Sato","year":"2010","unstructured":"Sato, S. & Kuwana, M. Clinically amyopathic dermatomyositis. Curr. Opin. Rheumatol. 22, 639\u2013643 (2010).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2011139_CR37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1684\/ejd.2010.0846","volume":"20","author":"Y Nagai","year":"2010","unstructured":"Nagai, Y., Mizuno, T., Yoshizawa, C. & Ishikawa, O. Fatal interstitial pneumonia in juvenile dermatomyositis. Eur. J. Dermatol. 20, 208\u2013210 (2010).","journal-title":"Eur. J. Dermatol."},{"key":"BFnrrheum2011139_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1442-200X.2009.02946.x","volume":"52","author":"Y Abe","year":"2010","unstructured":"Abe, Y. et al. Juvenile amyopathic dermatomyositis complicated by progressive interstitial pneumonia. Pediatr. Int. 52, 149\u2013153 (2010).","journal-title":"Pediatr. Int."},{"key":"BFnrrheum2011139_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3109\/s10165-010-0362-y","volume":"21","author":"K Azuma","year":"2010","unstructured":"Azuma, K. et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis, and clinically amyopathic dermatomyositis. Mod. Rhematol. 21, 178\u2013183 (2010).","journal-title":"Mod. Rhematol."},{"key":"BFnrrheum2011139_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","volume":"32","author":"P Morris","year":"2010","unstructured":"Morris, P. & Dare, J. Juvenile dermatomyositis as a paraneoplastic phenomenon: an update. J. Pediatr. Hematol. Oncol. 32, 189\u2013191 (2010).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"BFnrrheum2011139_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson, B., Lindelof, B., Edhag, O. & Allander, E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N. Engl. J. Med. 326, 363\u2013367 (1992).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2011139_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11926-011-0169-7","volume":"13","author":"ZA Zahr","year":"2011","unstructured":"Zahr, Z. A. & Baer, A. N. Malignancy in myositis. Curr. Rheumatol. Rep. 13, 208\u2013215 (2011).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum2011139_CR43","first-page":"739","volume":"21","author":"J Guzman","year":"1994","unstructured":"Guzman, J., Petty, R. E. & Malleson, P. N. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J. Rheumatol. 21, 739\u2013743 (1994).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","volume":"77","author":"A Vancsa","year":"2010","unstructured":"Vancsa, A. et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine 77, 125\u2013130 (2010).","journal-title":"Joint Bone Spine"},{"key":"BFnrrheum2011139_CR45","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","volume":"46","author":"LR Wedderburn","year":"2007","unstructured":"Wedderburn, L. R. et al. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology 46, 1786\u20131791 (2007).","journal-title":"Rheumatology"},{"key":"BFnrrheum2011139_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/adc.69.2.232","volume":"69","author":"F DeBenedetti","year":"1993","unstructured":"DeBenedetti, F., DeAmici, M., Aramini, L., Ruperto, N. & Martini, A. Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis. Arch. Dis. Child. 69, 232\u2013235 (1993).","journal-title":"Arch. Dis. Child."},{"key":"BFnrrheum2011139_CR47","first-page":"1681","volume":"48","author":"LG Rider","year":"2002","unstructured":"Rider, L. G. et al. Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies. Clin. Chem. 48, 1681\u20131688 (2002).","journal-title":"Clin. Chem."},{"key":"BFnrrheum2011139_CR48","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.24936","volume":"60","author":"H Bilgic","year":"2009","unstructured":"Bilgic, H. et al. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 60, 3436\u20133446 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/000155502753600894","volume":"82","author":"A Parodi","year":"2002","unstructured":"Parodi, A. et al. Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms, and circulating antibodies. Acta Derm. Venereol. 82, 48\u201351 (2002).","journal-title":"Acta Derm. Venereol."},{"key":"BFnrrheum2011139_CR50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer, R. et al. Autoantibody profiles in the sera of European patients with myositis. Ann. Rheum. Dis. 60, 116\u2013123 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2011139_CR51","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","volume":"6","author":"M Mahler","year":"2007","unstructured":"Mahler, M. & Raijmakers, R. Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights. Autoimmun. Rev. 6, 432\u2013437 (2007).","journal-title":"Autoimmun. Rev."},{"key":"BFnrrheum2011139_CR52","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/03009741003774626","volume":"39","author":"B Ranque","year":"2010","unstructured":"Ranque, B. et al. Myopathies related to systemic sclerosis: a case\u2013control study of associated clinical and immunological features. Scand. J. Rheumatol. 39, 498\u2013505 (2010).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrrheum2011139_CR53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.berh.2009.07.007","volume":"23","author":"LR Wedderburn","year":"2009","unstructured":"Wedderburn, L. R. & Rider, L. G. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract. Res. Clin. Rheumatol. 23, 665\u2013678 (2009).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"BFnrrheum2011139_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","volume":"70","author":"A Imbert-Masseau","year":"2003","unstructured":"Imbert-Masseau, A., Hamidou, M., Agard, C., Grolleau, J. Y. & Cherin, P. Antisynthetase syndrome. Joint Bone Spine 70, 161\u2013168 (2003).","journal-title":"Joint Bone Spine"},{"key":"BFnrrheum2011139_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena, H. et al. Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology 47, 324\u2013328 (2008).","journal-title":"Rheumatology"},{"key":"BFnrrheum2011139_CR56","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena, H. et al. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 60, 1807\u20131814 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji, K. et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46, 25\u201328 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR58","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3899\/jrheum.090461","volume":"36","author":"G Espada","year":"2009","unstructured":"Espada, G., Maldonado Cocco, J. A., Fertig, N. & Oddis, C. V. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J. Rheumatol. 36, 2547\u20132551 (2009).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR59","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/mus.21669","volume":"41","author":"S Khanna","year":"2010","unstructured":"Khanna, S. & Reed, A. M. Immunopathogenesis of juvenile dermatomyositis. Muscle Nerve 41, 581\u2013592 (2010).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum2011139_CR60","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(77)90487-1","volume":"2","author":"LM Pachman","year":"1977","unstructured":"Pachman, L. M., Jonasson, O., Cannon, R. A. & Friedman, J. M. Increased frequency of HLA-B8 in juvenile dermatomyositis. Lancet 2. 1238 (1977).","journal-title":"Lancet"},{"key":"BFnrrheum2011139_CR61","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/art.22216","volume":"54","author":"G Mamyrova","year":"2006","unstructured":"Mamyrova, G. et al. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum. 54, 3979\u20133987 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0198-8859(95)00035-6","volume":"44","author":"AM Reed","year":"1995","unstructured":"Reed, A. M. & Stirling, J. D. The HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis. Hum. Immunol. 44, 131\u2013135 (1995).","journal-title":"Hum. Immunol."},{"key":"BFnrrheum2011139_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0198-8859(91)90085-N","volume":"32","author":"AM Reed","year":"1991","unstructured":"Reed, A. M., Pachman, L. & Ober, C. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1*0501. Hum. Immunol. 32, 235\u2013240 (1991).","journal-title":"Hum. Immunol."},{"issue":"Suppl.","key":"BFnrrheum2011139_CR64","first-page":"S499","volume":"58","author":"MS Wagner","year":"2008","unstructured":"Wagner, M. S., McNallan, K. T., Crowson, C. S. & Reed, A. M. Discriminating functional variants in the IFN-inducible pathway in JDM and JIA. Arthritis Rheum. 58 (Suppl.), S499\u2013S500 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR65","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","volume":"43","author":"LM Pachman","year":"2000","unstructured":"Pachman, L. M. et al. TNF\u03b1\u2013308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor \u03b1, disease duration, and pathologic calcifications. Arthritis Rheum. 43, 2368\u20132377 (2000).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR66","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/rheumatology\/kem145","volume":"46","author":"H Chinoy","year":"2007","unstructured":"Chinoy, H. et al. Tumor necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology 46, 1411\u20131416 (2007).","journal-title":"Rheumatology"},{"key":"BFnrrheum2011139_CR67","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1002\/art.24039","volume":"58","author":"G Mamyrova","year":"2008","unstructured":"Mamyrova, G. et al. Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheum. 58, 3941\u20133950 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR68","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1002\/art.23900","volume":"58","author":"H Chinoy","year":"2008","unstructured":"Chinoy, H. et al. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum. 58, 3247\u20133254 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR69","first-page":"725","volume":"17","author":"L Miles","year":"2007","unstructured":"Miles, L. et al. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum. 17, 725\u2013730 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR70","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mus.21651","volume":"42","author":"A Pestronk","year":"2010","unstructured":"Pestronk, A., Schmidt, R. E. & Choksi, R. Vascular pathology in dermatomyositis and anatomic relations to myopathology. Muscle Nerve 42, 53\u201361 (2010).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum2011139_CR71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410270402","volume":"27","author":"AM Emslie-Smith","year":"1990","unstructured":"Emslie-Smith, A. M. & Engel, A. G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann. Neurol. 27, 343\u2013356 (1990).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum2011139_CR72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","volume":"56","author":"A Bohan","year":"1977","unstructured":"Bohan, A., Peter, J. B., Bowman, R. L. & Pearson, C. M. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56, 255\u2013286 (1977).","journal-title":"Medicine"},{"key":"BFnrrheum2011139_CR73","first-page":"285","volume":"52","author":"YJ Wang","year":"1993","unstructured":"Wang, Y. J. et al. Juvenile and adult dermatomyositis among the Chinese: a comparative study. Zhonghua Yi Xue Za Zhi (Taipei) 52, 285\u2013292 (1993).","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"BFnrrheum2011139_CR74","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.22558","volume":"56","author":"CM Lopez de Padilla","year":"2007","unstructured":"Lopez de Padilla, C. M. et al. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum. 56, 1658\u20131668 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR75","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0960-8966(96)00015-6","volume":"6","author":"JL De Bleecker","year":"1996","unstructured":"De Bleecker, J. L., Engel, A. G. & Butcher, E. C. Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies. Neuromuscul. Disord. 6, 255\u2013260 (1996).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum2011139_CR76","first-page":"136","volume":"75","author":"J Van der Pas","year":"2004","unstructured":"Van der Pas, J. Hengstman, G. J., ter Laak, H. J., Borm, G. F. & van Engelen, B. G. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J. Neurol. Neurosurg. Psychiatry 75, 136\u2013139 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrrheum2011139_CR77","first-page":"605","volume":"31","author":"CK Li","year":"2004","unstructured":"Li, C. K. et al. MHC Class I overexpression on muscles in early juvenile dermatomyositis. J. Rheumatol. 31, 605\u2013609 (2004).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR78","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/01.bor.0000179947.58271.9a","volume":"17","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju, K. Role of major histocompatibility complex class I molecules in autoimmune myositis. Curr. Opin. Rheumatol. 17, 725\u2013730 (2005).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2011139_CR79","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","volume":"65","author":"SA Greenberg","year":"2005","unstructured":"Greenberg, S. A. et al. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65, 1782\u20131787 (2005).","journal-title":"Neurology"},{"key":"BFnrrheum2011139_CR80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","volume":"137","author":"G Chevrel","year":"2003","unstructured":"Chevrel, G. et al. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 137, 125\u2013133 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnrrheum2011139_CR81","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/art.11428","volume":"50","author":"G Page","year":"2004","unstructured":"Page, G., Chevrel, G. & Miossec, P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 50, 199\u2013208 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cyto.2009.02.013","volume":"46","author":"A Tournadre","year":"2009","unstructured":"Tournadre, A. et al. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins. Cytokine 46, 297\u2013301 (2009).","journal-title":"Cytokine"},{"key":"BFnrrheum2011139_CR83","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.10140","volume":"46","author":"P Englund","year":"2002","unstructured":"Englund, P., Nennesmo, I., Klareskog, L. & Lundberg, I. E. Interleukin-1\u03b1 expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum. 46, 1044\u20131055 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2005.05.008","volume":"5","author":"AM Sallum","year":"2006","unstructured":"Sallum, A. M. et al. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. Autoimmun. Rev. 5, 93\u2013100 (2006).","journal-title":"Autoimmun. Rev."},{"key":"BFnrrheum2011139_CR85","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V","volume":"43","author":"I Lundberg","year":"2000","unstructured":"Lundberg, I., Kratz, A., Alexanderson, H. & Patarroyo, M. Decreased expression of interleukin-1\u03b1, interleukin-1\u03b2, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 43, 336\u2013348 (2000).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR86","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/art.27529","volume":"62","author":"S Shrestha","year":"2010","unstructured":"Shrestha, S. et al. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum. 62, 2813\u20132822 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR87","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju, K. et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 52, 1824\u20131835 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR88","first-page":"638","volume":"52","author":"PM Grimley","year":"1985","unstructured":"Grimley, P. M. et al. Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon. Lab. Invest. 52, 638\u2013649 (1985).","journal-title":"Lab. Invest."},{"key":"BFnrrheum2011139_CR89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/01913128609015565","volume":"10","author":"J Kuyama","year":"1986","unstructured":"Kuyama, J. et al. Formation of tubuloreticular inclusions in mitogen-stimulated human lymphocyte cultures by endogenous or exogenous alpha-interferon. Ultrastuct. Pathol. 10, 77\u201385 (1986).","journal-title":"Ultrastuct. Pathol."},{"key":"BFnrrheum2011139_CR90","first-page":"584","volume":"58","author":"D Feldman","year":"1988","unstructured":"Feldman, D., Goldstein, A. L., Cox, D. C. & Grimley, P. M. Cultured human endothelial cells treated with recombinant leukocyte A interferon. Tubuloreticular inclusion formation, antiproliferative effect, and 2\u2032, 5\u2032 oligoadenylate synthetase formation. Lab. Invest. 58, 584\u2013589 (1988).","journal-title":"Lab. Invest."},{"key":"BFnrrheum2011139_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0022-510X(96)00280-8","volume":"146","author":"M Tateyama","year":"1997","unstructured":"Tateyama, M. et al. Expression of tumor necrosis factor-\u03b1 in muscles of polymyositis. J. Neurol. Sci. 146, 45\u201351 (1997).","journal-title":"J. Neurol. Sci."},{"key":"BFnrrheum2011139_CR92","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1475-097X.2010.00973.x","volume":"31","author":"I Loell","year":"2011","unstructured":"Loell, I. et al. Higher proportion of fast-twitch (type II) muscle fibres in idiopathic inflammatory myopathies\u2014evident in chronic but not in untreated newly diagnosed patients. Clin. Physiol. Funct. Imaging 31, 18\u201325 (2011).","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"BFnrrheum2011139_CR93","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/art.22388","volume":"56","author":"C Grundtman","year":"2007","unstructured":"Grundtman, C. et al. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum. 56, 674\u2013687 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR94","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2169\/internalmedicine.47.0967","volume":"47","author":"W Ishii","year":"2008","unstructured":"Ishii, W. et al. Flow cytometric analysis of lymphocyte subpopulation and Th1\/Th2 balance in patients with polymyositis and dermatomyositis. Intern. Med. 47, 1593\u20131599 (2008).","journal-title":"Intern. Med."},{"key":"BFnrrheum2011139_CR95","first-page":"1830","volume":"24","author":"DM Eisenstein","year":"1997","unstructured":"Eisenstein, D. M., O'Gorman, M. R. & Pachman, L. M. Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis. J. Rheumatol. 24, 1830\u20131832 (1997).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR96","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/CDLI.7.4.693-697.2000","volume":"7","author":"MR O'Gorman","year":"2000","unstructured":"O'Gorman, M. R., Bianchi, L., Zaas, D., Corrochano, V. & Pachman, L. M. Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis. Clin. Diagn. Lab. Immunol. 7, 693\u2013697 (2000).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"BFnrrheum2011139_CR97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00005792-200303000-00002","volume":"82","author":"M Viguier","year":"2003","unstructured":"Viguier, M. et al. Blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine 82, 82\u201386 (2003).","journal-title":"Medicine"},{"key":"BFnrrheum2011139_CR98","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/S0140-6736(00)03500-5","volume":"356","author":"AM Reed","year":"2000","unstructured":"Reed, A. M., Shock, L. P. & Picornell, J. Chimerism in children with juvenile dermatomyositis. Lancet 356, 2156\u20132157 (2000).","journal-title":"Lancet"},{"key":"BFnrrheum2011139_CR99","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/S0140-6736(00)03499-1","volume":"356","author":"CM Artlett","year":"2000","unstructured":"Artlett, C. M. et al. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies: Childhood Myositis Heterogeneity Collaborative Group. Lancet 356, 2155\u20132156 (2000).","journal-title":"Lancet"},{"key":"BFnrrheum2011139_CR100","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.4049\/jimmunol.172.8.5041","volume":"172","author":"AM Reed","year":"2004","unstructured":"Reed, A. M., McNallan, K., Wettstein, P., Vehe, R. & Ober, C. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J. Immunol. 172, 5041\u20135046 (2004).","journal-title":"J. Immunol."},{"key":"BFnrrheum2011139_CR101","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11926-003-0054-0","volume":"5","author":"AM Stevens","year":"2003","unstructured":"Stevens, A. M. Foreign cells in polymyositis: could stem cell transplantation and pregnancy-derived chimerism lead to the same disease? Curr. Rheumatol. Rep. 5, 437\u2013444 (2003).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum2011139_CR102","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","volume":"47","author":"C Manlhiot","year":"2008","unstructured":"Manlhiot, C. et al. Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. Rheumatology 47, 526\u2013529 (2008).","journal-title":"Rheumatology"},{"key":"BFnrrheum2011139_CR103","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/art.21068","volume":"53","author":"LM Pachman","year":"2005","unstructured":"Pachman, L. M. et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum. 53, 166\u2013172 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR104","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/art.1780381019","volume":"38","author":"LM Pachman","year":"1995","unstructured":"Pachman, L. M. et al. Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum. 38, 1513\u20131518 (1995).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR105","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/art.22751","volume":"56","author":"LJ Vegosen","year":"2007","unstructured":"Vegosen, L. J. et al. Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. Arthritis Rheum. 56, 2719\u20132728 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR106","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.24702","volume":"60","author":"LA Love","year":"2009","unstructured":"Love, L. A. et al. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 60, 2499\u20132504 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR107","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1002\/art.21378","volume":"52","author":"AV Ramanan","year":"2005","unstructured":"Ramanan, A. V. et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum. 52, 3570\u20133578 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR108","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3899\/jrheum.090953","volume":"37","author":"E Stringer","year":"2010","unstructured":"Stringer, E. et al. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. J. Rheum. 37, 1953\u20131961 (2010).","journal-title":"J. Rheum."},{"issue":"Suppl. 1","key":"BFnrrheum2011139_CR109","first-page":"S53","volume":"199","author":"J Miller","year":"2002","unstructured":"Miller, J., Walsh, Y. & Saminaden, S. Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy. J. Neurol. Sci. 199 (Suppl. 1) S53 (2002).","journal-title":"J. Neurol. Sci."},{"key":"BFnrrheum2011139_CR110","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"J Vencovsky","year":"2000","unstructured":"Vencovsky, J. et al. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand. J. Rheumatol. 29, 95\u2013102 (2000).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrrheum2011139_CR111","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","volume":"41","author":"L Villalba","year":"1998","unstructured":"Villalba, L. et al. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum. 41, 392\u2013399 (1998).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR112","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas, M. C. et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N. Engl. J. Med. 329, 1993\u20132000 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2011139_CR113","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/acr.20325","volume":"62","author":"I Marie","year":"2010","unstructured":"Marie, I. et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res. 62, 1748\u20131755 (2010).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum2011139_CR114","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1542\/peds.2007-1218","volume":"121","author":"C Manlhiot","year":"2008","unstructured":"Manlhiot, C. et al. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content. Pediatrics 121, e626\u2013e630 (2008).","journal-title":"Pediatrics"},{"key":"BFnrrheum2011139_CR115","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/acr.20269","volume":"62","author":"KA Rouster-Stevens","year":"2010","unstructured":"Rouster-Stevens, K. A., Morgan, G. A., Wang, D. & Pachman, L. M. Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis. Arthritis Care Res. 62, 1446\u20131451 (2010).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum2011139_CR116","doi-asserted-by":"publisher","unstructured":"Dagher, R. et al. Mycophenolate mofetil in juvenile dermatomyositis: a case series. Rheumatol. Int. http:\/\/dx.doi.org\/10.1007\/s00296-010-1653-5 .","DOI":"10.1007\/s00296-010-1653-5"},{"key":"BFnrrheum2011139_CR117","first-page":"2436","volume":"24","author":"A Reiff","year":"1997","unstructured":"Reiff, A. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J. Rheumatol. 24, 2436\u20132443 (1997).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR118","first-page":"1424","volume":"23","author":"V Zeller","year":"1996","unstructured":"Zeller, V., Cohen, P., Prieur, A. M. & Guillevin, L. Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. J. Rheumatol. 23, 1424\u20131427 (1996).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR119","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","volume":"47","author":"P Riley","year":"2008","unstructured":"Riley, P. et al. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) 47, 877\u2013880 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR120","first-page":"135","volume":"28","author":"A Marco Puche","year":"2010","unstructured":"Marco Puche, A., Calvo Penades, I. & Lopez Montesinos, B. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis. Clin. Exp. Rheumatol. 28, 135\u2013140 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2011139_CR121","first-page":"2152","volume":"23","author":"MB Oliveri","year":"1996","unstructured":"Oliveri, M. B., Palermo, R., Mautalen, C. & Hubscher, O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J. Rheumatol 23, 2152\u20132155 (1996).","journal-title":"J. Rheumatol"},{"key":"BFnrrheum2011139_CR122","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/rheumatology\/39.3.333","volume":"39","author":"CS Vinen","year":"2000","unstructured":"Vinen, C. S., Patel, S. & Bruckner, F. E. Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy. Rheumatology (Oxford) 39, 333\u2013334 (2000).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR123","first-page":"1009","volume":"27","author":"R Rios Fernandez","year":"2009","unstructured":"Rios Fernandez, R., Callejas Rubio, J. L., Sanchez Cano, D., Saez Moreno, J. A. & Ortego Centeno, N. Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature. Clin. Exp. Rheumatol. 27, 1009\u20131016 (2009).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2011139_CR124","first-page":"3844","volume":"62","author":"CV Oddis","year":"2010","unstructured":"Oddis, C. V. et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis (DM) and adult polymyositis (PM)\u2014The RIM Study [abstract L13]. Arthritis Rheum. 62, 3844 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/acr.20171","volume":"62","author":"AM Huber","year":"2010","unstructured":"Huber, A. M. et al. Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res. 62, 219\u2013225 (2010).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum2011139_CR126","doi-asserted-by":"crossref","unstructured":"Robinson, A. B. et al. Diagnostic evaluation and medication usage in a cohort of subjects with JDM from the CARRAnet Registry. Poster presented at the American College of Rheumatology Pediatric Rheumatology Symposium 2011.","DOI":"10.1186\/1546-0096-10-S1-A64"},{"key":"BFnrrheum2011139_CR127","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman, B. M., Rider, L. G., Reed, A. M. & Pachman, L. M. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371, 2201\u20132212 (2008).","journal-title":"Lancet"},{"key":"BFnrrheum2011139_CR128","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"N Martin","year":"2007","unstructured":"Martin, N. et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; The Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology 50, 137\u2013145 (2007).","journal-title":"Rheumatology"},{"key":"BFnrrheum2011139_CR129","first-page":"1593","volume-title":"Arthritis and Allied Conditions: A Textbook of Rheumatology","author":"FW Miller","year":"2005","unstructured":"Miller, F. W. In Arthritis and Allied Conditions: A Textbook of Rheumatology 15th edn (eds Koopman, W. & Moreland, L) 1593\u20131620 (Lippincott Williams & Wilkins, Philadelphia, (2005)."},{"key":"BFnrrheum2011139_CR130","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","volume":"88","author":"L Fardet","year":"2009","unstructured":"Fardet, L. et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine 88, 91\u201397 (2009).","journal-title":"Medicine"},{"key":"BFnrrheum2011139_CR131","first-page":"493","volume":"52","author":"AV Ramanan","year":"2005","unstructured":"Ramanan, A. V. & Feldman, B. M. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum. Dis. Clin. North Am. 52, 493\u2013520 (2005).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrrheum2011139_CR132","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.semarthrit.2008.09.003","volume":"39","author":"A Selva-O'Callaghan","year":"2010","unstructured":"Selva-O'Callaghan, A. et al. Nailfold capillary microscopy in adults with inflammatory myopathy. Semin. Arthritis Rheum. 39, 398\u2013404 (2010).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2011139_CR133","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3346\/jkms.2009.24.4.715","volume":"24","author":"SJ Na","year":"2009","unstructured":"Na, S. J., Kim, S. M., Sunwoo, I. N. & Choi, Y. C. Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J. Korean Med. Sci. 24, 715\u2013721 (2009).","journal-title":"J. Korean Med. Sci."},{"key":"BFnrrheum2011139_CR134","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","volume":"43","author":"AM Huber","year":"2000","unstructured":"Huber, A. M. et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum. 43, 541\u2013549 (2000).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR135","first-page":"192","volume":"28","author":"S Tse","year":"2001","unstructured":"Tse, S. et al. The arthritis of inflammatory childhood myositis syndromes. J. Rheumatol. 28, 192\u2013197 (2001).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2011139_CR136","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/000155502753600894","volume":"82","author":"A Parodi","year":"2002","unstructured":"Parodi, A. et al. Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies. Acta Derm. Venereol. 82, 48\u201351 (2002).","journal-title":"Acta Derm. Venereol."},{"key":"BFnrrheum2011139_CR137","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1471-2474-11-223","volume":"11","author":"EH Kang","year":"2010","unstructured":"Kang, E. H. et al. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis. BMC Musculoskelet. Disord. 11, 223 (2010).","journal-title":"BMC Musculoskelet. Disord."},{"key":"BFnrrheum2011139_CR138","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/art.22205","volume":"54","author":"TP O'Hanlon","year":"2006","unstructured":"O'Hanlon, T. P. et al. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 54, 3670\u20133681 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR139","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/art.21883","volume":"54","author":"Y Yamasaki","year":"2006","unstructured":"Yamasaki, Y. et al. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis. Arthritis Rheum. 54, 2004\u20132009 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR140","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer, R. et al. Autoantibody profiles in the sera of European patients with myositis. Ann. Rheum. Dis. 60, 116\u2013123 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2011139_CR141","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/art.11090","volume":"48","author":"S Okada","year":"2003","unstructured":"Okada, S. et al. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 48, 2285\u20132293 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR142","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","volume":"49","author":"K Hoshino","year":"2010","unstructured":"Hoshino, K. et al. Anti-MDA5 and anti-TIF1-\u03b3 antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford) 49, 1726\u20131733 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR143","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji, K. et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46, 25\u201328 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR144","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2010","unstructured":"Nakashima, R. et al. The RIG-1-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 49, 433\u2013440 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR145","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","volume":"40","author":"I Hausmanowa-Petrusewicz","year":"1997","unstructured":"Hausmanowa-Petrusewicz, I. et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40, 1257\u20131266 (1997).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR146","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/35.9.839","volume":"35","author":"F Iannone","year":"1996","unstructured":"Iannone, F. et al. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis. Br. J. Rheumatol. 35, 839\u2013845 (1996).","journal-title":"Br. J. Rheumatol."},{"key":"BFnrrheum2011139_CR147","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.5858\/2007-131-1070-MHCCIA","volume":"131","author":"A Jain","year":"2007","unstructured":"Jain, A. et al. Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies. Arch. Pathol. Lab. Med. 131, 1070\u20131076 (2007).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrrheum2011139_CR148","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/art.23012","volume":"57","author":"LR Wedderburn","year":"2007","unstructured":"Wedderburn, L. R. et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum. 57, 1192\u20131201 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR149","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2249.2004.02500.x","volume":"137","author":"K Mizuno","year":"2004","unstructured":"Mizuno, K. et al. Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer\/effector phenotypes in juvenile dermatomyositis syndrome. Clin. Exp. Immunol. 137, 189\u2013194 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2011139_CR150","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3346\/jkms.2009.24.6.1015","volume":"24","author":"JH Choi","year":"2009","unstructured":"Choi, J. H. et al. Differential immunohistological features of inflammatory myopathies and dysferlinopathy. J. Korean Med. Sci. 24, 1015\u20131023 (2009).","journal-title":"J. Korean Med. Sci."},{"key":"BFnrrheum2011139_CR151","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1365-2230.2006.02150.x","volume":"31","author":"J Wenzel","year":"2006","unstructured":"Wenzel, J. et al. Type 1 interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin. Exp. Dermatol. 31, 576\u2013581 (2006).","journal-title":"Clin. Exp. Dermatol."},{"key":"BFnrrheum2011139_CR152","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","volume":"225","author":"A Waschbisch","year":"2010","unstructured":"Waschbisch, A., Schwab, N., Ruck, T., Stenner, M. P. & Wiendl, H. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J. Neuroimmunol. 225, 137\u2013142 (2010).","journal-title":"J. Neuroimmunol."},{"key":"BFnrrheum2011139_CR153","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jaut.2010.07.006","volume":"35","author":"E Antiga","year":"2010","unstructured":"Antiga, E. et al. Characterization of regulatory T cells in patients with dermatomyositis. J. Autoimmun. 35, 342\u2013350 (2010).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum2011139_CR154","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/art.1780250203","volume":"25","author":"WE Crowe","year":"1982","unstructured":"Crowe, W. E., Bove, K. E., Levinson, J. E. & Hilton, P. K. Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum. 25, 126\u2013139 (1982).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR155","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel, J. T., Mendell, J. R. & Rammohan, K. W. Microvascular deposition of complement membrane attack complex in dermatomyositis. N. Engl. J. Med. 314, 329\u2013334 (1986).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2011139_CR156","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1600-0404.2010.01353.x","volume":"123","author":"A Jain","year":"2011","unstructured":"Jain, A. et al. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis. Acta Neurol. Scand. 123, 122\u2013129 (2011).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrrheum2011139_CR157","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/art.22388","volume":"56","author":"C Grundtman","year":"2007","unstructured":"Grundtman, C. et al. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum. 56, 674\u2013687 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2011139_CR158","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1006\/clim.2001.5063","volume":"100","author":"TO Fedczyna","year":"2001","unstructured":"Fedczyna, T. O., Lutz, J. & Pachman, L. M. Expression of TNF\u03b1 by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNF\u03b1\u2013308A allele. Clin. Immunol. 100, 236\u2013239 (2001).","journal-title":"Clin. Immunol."},{"key":"BFnrrheum2011139_CR159","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaut.2006.06.003","volume":"27","author":"AB Hassan","year":"2006","unstructured":"Hassan, A. B., Fathi, M., Dastmalchi, M., Lundberg, I. E. & Padyukov, L. Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis. J. Autoimmun. 27, 62\u201368 (2006).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum2011139_CR160","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/rheumatology\/kep035","volume":"48","author":"H Chinoy","year":"2009","unstructured":"Chinoy, H. et al. Clinical, serological and HLA profiles in non-Caucasian UK idiopathic inflammatory myopathy. Rheumatology (Oxford) 48, 591\u2013592 (2009).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2011139_CR161","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","volume":"84","author":"TP O'Hanlon","year":"2005","unstructured":"O'Hanlon, T. P. et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA\u2013A, \u2212B, \u2212Cw, \u2212DRB1 and \u2212DQA1 allelic profiles and motifs define clinicopathologic groups in Caucasians. Medicine (Baltimore) 84, 338\u2013349 (2005).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrrheum2011139_CR162","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar1862","volume":"8","author":"H Chinoy","year":"2006","unstructured":"Chinoy, H. et al. In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res. Ther. 8, R13 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2011139_CR163","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11926-996-0007-5","volume":"3","author":"LM Pachman","year":"2001","unstructured":"Pachman, L. M., Fedczyna, T. O., Lechman, T. S. & Lutz, J. Juvenile dermatomyositis: the association of the TNF alpha\u2013308A allele and disease chronicity. Curr. Rheumatol. Rep. 3, 379\u2013386 (2001).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum2011139_CR164","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1046\/j.1523-1747.2002.01869.x","volume":"119","author":"VP Werth","year":"2002","unstructured":"Werth, V. P., Callen, J. P., Ang, G. & Sullivan, K. E. Associations of tumor necrosis factor \u03b1 and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis. J. Invest. Dermatol. 119, 617\u2013620 (2002).","journal-title":"J. Invest. Dermatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:28:04Z","timestamp":1684456084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2011.139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":164,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFnrrheum2011139"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2011.139","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]}}}